Pfizer Inc
NYSE: PFE
$29.50
-$0.17 (-0.6%)
Real Time Data Delayed 15 Min.
PFE Articles
Antigenics Inc. (NASDAQ: AGEN) A study for Cancer vaccine, Oncophage, for the treatment of metastatic melanoma showed mixed results this morning. Shares are down almost 7% to $2.17. The 52 week...
Published:
Icagen Inc. (NASDAQ: ICGN) has announced that it has provided notice to exercise its put option with Pfizer Inc. (NYE: PFE). This is for the private placement of approximately $10 million of Icagen...
Published:
2008 is turning out to be a wacky year. If you are new to trading and investing this is far from the norm. Statistics vary depending on what day of the week it is but this is the worst January...
Published:
Last Updated:
Pfizer Inc. (NYSE: PFE) has posted earnings that are lower than last year’s results, but were actually above analyst expectations from First Call. The drug giant posted $0.52 EPS versus $0.47...
Published:
Last Updated:
Monday is a market holiday in observance of Martin Luther King Day in the U.S. But after that we have an earnings deluge with hundreds of companies issuing their earnings. For the bulk of the...
Published:
Last Updated:
Short interest of stocks listed on the NYSE as of December 31 showed that retailers and financial companies had sharp increases when compared to the figures on December 14. Shares sold short in...
Published:
We are updating our list of tier-one Defensive Stocks since so many of these stocks have run up and since lists need continual updating. Our originally updated list of tier one defensive stocks was...
Published:
Last Updated:
We compiled a list of many companies that just haven’t been able to turn themselves around. On some we offered a road out and on others we feel sorry for the management because getting out of the...
Published:
Last Updated:
The Dogs of the Dow aren’t necessarily the worst performers of the prior year, but they pay the highest the dividend yields. We wanted to review the 10 Dogs of the Dow to see what the outlook and...
Published:
Last Updated:
For the December 14 period, short interest in financial stocks sky-rocketed compared to figures on November 30. Shares sold short in Citigroup (C) grew 20 million to 104.9 million. Shares short in...
Published:
Since it is year-end, we wanted to compile a list of the 2008 likely Dogs of the Dow. We included Friday’s closing prices for each DJIA component and we also gave the current dividend yield. It...
Published:
According to Reuters, Oracle (ORCL) posted strong earnings and offered a robust outlook for its business. Reuters writes that Barclays (BCS) has sued Bear Stearns (BSC) over losses in two hedge funds...
Published:
Early this week we are running a list of stocks that have been in a turnaround plan, yet the stocks and the businesses haven’t turned around. Could these be the stocks to watch for 2008? Pfizer...
Published:
Last Updated:
Biogen-Iden (NASDAQ:BIIB) is seeing its shares pummeled in after-hours trading. The company didn’t have another biotech drug crisis though. Biogen had been under a corporate strategic review...
Published:
Last Updated:
It is always interesting seeing which groups and which stocks saw the biggest changes in short interest. This list doesn’t show financials because we’ve already shown that individually. Here...
Published:
Last Updated: